Patents by Inventor Erin TRACY

Erin TRACY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Epidermal growth factor receptor (EGFR) targeted photosensitizers
    Patent number: 11083793
    Abstract: Compounds including a tetrapyrrolic or reduced tetrapyrrolic group/moiety and an epidermal growth factor receptor targeting group are disclosed. For example, a compound includes a tetrapyrrolic or reduced tetrapyrrolic group or moiety, a linker moiety, an epidermal growth factor receptor targeting group, and, optionally, a PET-active functional group. Uses of the compounds, for example, methods of treating a hyperproliferative tissue in an individual, and kits including one or more of the compounds are also provided.
    Type: Grant
    Filed: December 13, 2017
    Date of Patent: August 10, 2021
    Assignees: Health Research, Inc., Photolitec, LLC
    Inventors: Ravindra K. Pandey, Heinz Baumann, Khurshid Guru, Ravindra Cheruku, Erin Tracy, Farukh Durrani, Joseph Cacaccio, Kevin Siters
  • EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) TARGETED PHOTOSENSITIZERS
    Publication number: 20200078461
    Abstract: Compounds including a tetrapyrrolic or reduced tetrapyrrolic group/moiety and an epidermal growth factor receptor targeting group are disclosed. For example, a compound includes a tetrapyrrolic or reduced tetrapyrrolic group or moiety, a linker moiety, an epidermal growth factor receptor targeting group, and, optionally, a PET-active functional group. Uses of the compounds, for example, methods of treating a hyperproliferative tissue in an individual, and kits including one or more of the compounds are also provided.
    Type: Application
    Filed: December 13, 2017
    Publication date: March 12, 2020
    Inventors: Ravindra K. PANDEY, Heinz BAUMANN, Khurshid GURU, Ravindra CHERUKI, Erin TRACY, Farukh DURRANI, Joseph CACACCIO, Kevin SITERS